SpeculatingStocks   UserStream  Reactions  Data  Stock Buzz  Market  Pre  AH  Technicals  ETFs  Articles  Picks  Compare Stocks  Portal  Buckets  Post  Join  ☰
Remember
Forgot Pass?
 
 
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.
AFMD Stream, Posts, Sentiment, Activity ↘
 HPR  WWD  NEE  SANM  EVFM  MDR
 

AFMD
 
 

AFMD (Affimed Therapeutics B.V.) · Research · Financials · News · Comments · Reactions · React Anonymously to $AFMD, Now!

 
  $2.15   +0.03   +1.18%  

 

 
 

AFMD 'Buy' / 'Sell' Stats
 
Sentiment Over the Last:  
  10-Mins: B:0 S:0  
  1-Hour: B:0 S:0  
6-Hours: B:0 S:0
1-Day: B:0 S:0
3-Days: B:0 S:0
1-Week: B:0 S:0
and more... sign up.
More AFMD Social Data
 

AFMD in Data Terminal

  
Research AFMD /w Social & Financial Data on AFMD
 

Top Stories Today 4m

  
 

AFMD Stats
 

Followers: 0

 		 
 

'Buys': 0

 		 
 

'Sells': 0

 		 
 

Go to a Symbol Page
 
  Go to a User Profile
 
 

Follow AFMD on Pulse
 
Sign Up for SpeculatingStocks Pulse: A Social Network for Investors
 

Global Streams
 
PulseStream
SpecStream
UserStream
Reactions
EchoStream
 

Stock Data Terminal

  
Stock Market Data
  SpecStream Components
 
SpecStream Trending Stock Exchanges S&P Premarket Gainers & Losers Morning Earning Releases Futures After the Bell Earning Releases Technical Indicators ETF Movers Market Cap Milestones Current Movers - Gainers Current Movers - Decliners Headlines Media Buzz Economic News Top Stories Pulse User Buys Pulse User Sells B/S Today Pos. Sent. Milestones B/S Today Neg. Sent. Milestones Stock Follower Milestones Corporate Alerts Short Squeeze Alerts Price to Earnings PE Alerts Price to Sales PS Alerts Price to Book PB Alerts Insider Holding Alerts Institutional Holding Alerts Low Float Stocks Profitable or Not Cash Flow Positive High Beta Volatile Stocks Stocks Followed by Users
 
 

$AFMD Stream | Posts: · Avg/Day:

$AFMD Reactions		    

Affimed Therapeutics B.V. ($AFMD)


Affimed NV is a clinical stage biopharmaceutical company, which engages in discovering and developing highly ... More | Chart | Post
Institutional Holding Alerts
$AFMD (Affimed Therapeutics B.V.) has significant institutional ownership of at least 20% with institutional ownership of 62.19%.
6 days ago | 0 buys, 0 sells
+1
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
High Beta Volatile Stocks
$AFMD (Affimed Therapeutics B.V.) is significantly more volatile than the overall market with a Beta of 2.14.
6 days ago | 0 buys, 0 sells
0
React Anonymously
Technical Indicators
Bullish MACD Crossovers: $ACCO, $ACM, $AFMD, $AFSI, $ALG, $AOM, $ASIX, $AXP, $AXTA, $B.
More than 2 wks ago | 0 buys, 0 sells
+1
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
Institutional Holding Alerts
$AFMD (Affimed Therapeutics B.V.) has significant institutional ownership of at least 20% with institutional ownership of 40.46%.
More than 3 wks ago | 0 buys, 0 sells
+1
React Anonymously
Profitable or Not
$AFMD (Affimed Therapeutics B.V.) did not produce a profit last quarter with Quarterly Net Income of $(7.56M).
More than 3 wks ago | 0 buys, 0 sells
0
React Anonymously
Cash Flow Positive
$AFMD (Affimed Therapeutics B.V.) is cash flow positive as of at least the last quarter with Quarterly Cash Flow of $7.28M.
More than 3 wks ago | 0 buys, 0 sells
+1
React Anonymously
Current Movers - Decliners
$AFMD (Affimed Therapeutics B.V.) is down more than 5%, reaching a new downside threshold.
More than 3 wks ago | 0 buys, 0 sells
+4
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
Technical Indicators
50/200-day Moving Average Crossovers: $AFMD, $AMTX, $BSGM, $ISNS, $IVOB, $KEYW, $MCS, $TRX, $USM, $VIIX.
More than 3 wks ago | 0 buys, 0 sells
+1
React Anonymously
Current Movers - Decliners
$AFMD (Affimed Therapeutics B.V.) is down more than 5%, reaching a new downside threshold.
More than 3 wks ago | 0 buys, 0 sells
+4
React Anonymously
Institutional Holding Alerts
$AFMD (Affimed Therapeutics B.V.) has significant institutional ownership of at least 20% with institutional ownership of 40.17%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
Pre-NASDAQ Losers
Top pre-market decliners: $XNCR ⇓ -5.18%, $AAL ⇓ -2.39%, $AFMD ⇓ -2.38%, $GBT ⇓ -1.89% and $DGLD ⇓ -1.79%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
Pre-NASDAQ Losers
Top pre-market decliners: $XNCR ⇓ -4.87%, $AAL ⇓ -2.39%, *$AFMD ⇓ -2.38%, $GBT ⇓ -1.89% and *$DGLD ⇓ -1.79%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
+8
React Anonymously
Morning Earning Releases
Earning Releases this morning: $AFMD, $ATD, $CHFS, $PLCE, $DLTH.
More than 1 mo ago | 0 buys, 0 sells
0
React Anonymously
SpecStream Trending
Stocks trending in the SpecStream: $AFMD, $TRUE, $IPGP, $SIMO, $GLYC, $MU, $MRNS, $PTI, $HAIN, $NVCR.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
After NASDAQ Gainers
Top after-hours gainers: $ARNA ⇑ +23.83%, *$ELGX ⇑ +8.17%, *$TRUE ⇑ +7.90%, $MRNS ⇑ +7.33%, $IOVA ⇑ +5.76%, $AFMD ⇑ +5.00% and $SIMO ⇑ +3.99%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
After NASDAQ Gainers
Top after-hours gainers: $ARNA ⇑ +23.83%, $TRUE ⇑ +7.90%, $ELGX ⇑ +7.93%, $MRNS ⇑ +6.11%, $IOVA ⇑ +5.76%, $AFMD ⇑ +5.00% and $SIMO ⇑ +3.99%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
After NASDAQ Gainers
Top after-hours gainers: $ARNA ⇑ +24.54%, $TRUE ⇑ +7.90%, $ELGX ⇑ +7.93%, $MRNS ⇑ +6.11%, $IOVA ⇑ +5.76%, $AFMD ⇑ +5.00% and $SIMO ⇑ +3.99%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
After NASDAQ Gainers
Top after-hours gainers: $ARNA ⇑ +24.80%, $TRUE ⇑ +7.90%, $ELGX ⇑ +7.93%, $MRNS ⇑ +7.33%, *$IOVA ⇑ +5.76%, *$AFMD ⇑ +5.00% and *$SIMO ⇑ +3.99%.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously
specstocks
Moments ago | 0 buys, 0 sells
+5
React Anonymously
SpecStream Trending
Stocks trending in the SpecStream: $ARNA, $SHLX, $IOVA, $GDEN, $EBAY, $GLYC, $MDLZ, $AMTX, $AFMD, $ELGX.
More than 1 mo ago | 0 buys, 0 sells
+1
React Anonymously

 



Go to Reactions Related to AFMD!


Don't have a Free SpeculatingStocks Account? Feel free to Post Anonymously or Leave Your Comment Below on Affimed Therapeutics B.V. (AFMD) with your FB Social Media Account:


 

Reactions Related to $AFMD · All Reactions Stream Live

  



Your reaction and other reactions to $AFMD pulses will show here!

Post a reaction by clicking the "React Anonymously" link in any of the pulse posts in the stream above. No account required.

Want to react with an account? Get a Free Account.
 
 

AFMD Sentiment Today (Since 7 AM ET)

 
 

0

 
 

Live AFMD Activity

 
Be the First Pulse User to Follow, 'Buy', or 'Sell' AFMD. Instant Access Now to Pulse.
  The Revolution in Speculation Continues... 21,731 symbol pages... 947 users... 1,127,665 pulses... not one unhappy user. Sign up now, free!

Newest SpeculatingStocks Pulse User 

pinizzottof
  402 Crowdsourced Stock Ratings Inside...
 

AFMD Snapshot · Research AFMD

 
 

AFMD

  (More Inside)      
  Volume: 138,448  
  Market Cap: $132.58M  
  Exchange: Nasdaq  
  Website: http://www.affimed.com  
  More AFMD Metrics  
 
 
  
   
   
  Industry: Health Care/Life Sciences  
  Affimed NV is a clinical stage biopharmaceutical company, which engages in discovering and developing highly targeted cancer immunotherapies. The company has three proprietary platform technologies which includes: NK-cell TandAbs, T-cell TandAbs and Trispecific Abs....  
 
More AFMD Corporate Data 		 
 

AFMD Buzz

 
 

Headlines for Affimed Therapeutics B.V. (AFMD)

  
  Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy Press Release 04/16/18  
  Affimed Reports Financial Results for Fourth Quarter and Year End 2017 Press Release 03/20/18  
  ( AFMD ) Affimed N.V. to Host Earnings Call Press Release 03/20/18  
  Affimed Appoints Dr. Leila Alland as Chief Medical Officer Press Release 03/19/18  
  Affimed to Present Data on AFM24 at AACR Annual Meeting 2018 Press Release 03/15/18  
 


News Headlines for Affimed Therapeutics B.V. (AFMD)